Mutations in the beta-subunit of the epithelial Na+ channel in patients with a cystic fibrosis-like syndrome

Human Molecular Genetics

Volumn 14, Issue 22, 2005, Pages 3493-3498

  Sheridan, Molly B ^a   Fong, Peying ^a   Groman, Joshua D ^a   Conrad, Carol ^b   Flume, Patrick ^c   Diaz, Ruben ^d   Harris, Christopher ^e   Knowles, Michael ^f   Cutting, Garry R ^a,g  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d UNIVERSITY OF NEVADA   (United States)

^e VANDERBILT UNIVERSITY   (United States)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

^g DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; PROTEIN SCNN1; SODIUM CHANNEL; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BETA CHAIN; CHLORIDE TRANSPORT; CLINICAL FEATURE; CONTROLLED STUDY; CYSTIC FIBROSIS; EPITHELIUM CELL; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN CELL; LIDDLE SYNDROME; MAJOR CLINICAL STUDY; NONHUMAN; NOSE MUCOSA; NUCLEOTIDE SEQUENCE; OOCYTE; PRIORITY JOURNAL; PSEUDOHYPOALDOSTERONISM; RNA ANALYSIS; SCHOOL CHILD; SODIUM TRANSPORT; VOLTAGE CLAMP; XENOPUS;

ADULT; AMINO ACID SEQUENCE; ANIMALS; CHILD; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL SODIUM CHANNEL; FEMALE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PEDIGREE; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; SODIUM; SODIUM CHANNELS; SYNDROME;

EID: 27944483003     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddi374     Document Type: Article

References (21)

1. Welsh, M.J., Ramsey, B.W., Accurso, F.J. and Cutting, G.R. (2001) In Scriver, C.R., Beaudet, A.L., Valle, D. and Sly, W.S. (eds), The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill, Inc., New York, Vol. 111, pp, 5121-5188.
2. Mekus, F., Ballmann, M., Bronsveld, I., Dörk, T., Bijman, J. and Tummler, B. (1998) Cystic-fibrosis-like disease unrelated to the cystic fibrosis transmembrane conductance regulator. Hum. Genet., 102, 582-586.
3. Hughes, D., Dork, T., Stuhrmann, M. and Graham, C. (2001) Mutation and haplotype analysis of the CFTR gene in atypically mild cystic fibrosis patients from Northern Ireland. J. Med. Genet., 38, 136-139.
4. Groman, J.D., Meyer, M.E., Wilmott, R.W., Zeitlin, P.L. and Cutting, G.R. (2002) Variant cystic fibrosis phenotypes in the absence of CFTR mutations. N. Engl. J. Med., 347, 401-407.
5. Wallis, C. (2003) Atypical cystic fibrosis - diagnostic and management dilemmas. J. R. Soc. Med., 96 (Suppl. 43), 2-10.
6. Stutts, M.J., Canessa, C.M., Olsen, J.C., Hamrick, M., Cohn, J.A., Rossier, B.C. and Boucher, R.C. (1995) CFTR as a cAMP-dependent regulator of sodium channels. Science, 269, 847-850.
7. - channel function. Nature, 402, 301-304.
8. Groman, J.D., Karczeski, B., Sheridan, M., Robinson, T.E., Fallin, M.D. and Cutting, G.R. (2005) Phenotypic and genetic characterization of patients with features of 'nonclassic' forms of cystic fibrosis. J. Pediatr., 146, 675-680.
9. + channel is made of three homologous subunits. Nature, 367,463-467.
10. Chang, S.S., Grunder, S., Hanukoglu, A., Rosler, A., Mathew, P.M., Hanukoglu, I., Schild, L., Lu, Y., Shimkets, R.A., Nelson-Williams, C. et al. (1996) Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat. Genet., 12, 248-253.
11. Shimkets, R.A., Warnock, D.G., Bositis, C.M., Nelson-Williams, C., Hansson, J.H., Schambelan, M., Gill, J.R., Jr, Ulick, S., Milora, R.B., Findling, J.W. et al. (1994) Liddle's syndrome: Heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel. Cell, 79, 407-414.
12. Gharvi, A., Lifton, R.P. (2001) In Scriver, C.R., Beaudet, A.L., Sly, W.S., and Valle, D. (eds), The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill, Inc., New York, pp. 5399-5417.
13. Kerem, E., Bistritzer, T., Hanukoglu, A., Hofmann, T., Zhou, Z., Bennett, W., MacLaughlin, E., Barker, P., Nash, M., Quittell, L. et al. (1999) Pulmonary epithelial sodium-channel dysfunction and excess airway liquid in pseudohypoaldosteronism. N. Engl. J. Med., 341, 156-162.
14. Marthinsen, L., Kornfalt, R., Aili, M., Andersson, D., Westgren, U. and Schaedel, C. (1998) Recurrent Pseudomonas bronchopneumonia and other symptoms as in cystic fibrosis in a child with type I pseudohypoaldosteronism. Acta Paediatr., 87, 472-474.
15. Schaedel, C., Marthinsen, L., Kristoffersson, A.C., Kornfalt, R., Nilsson, K.O., Orlenius, B. and Holmberg, L. (1999) Lung symptoms in pseudohypoaldosteronism type 1 are associated with deficiency of the alpha-subunit of the epithelial sodium channel. J. Pediatr., 135, 739-745.
16. Baker, E., Jeunemaitre, X:, Portal, A.J., Grimbert, P., Markandu, N., Persu, A., Corvol, P. and MacGregor, G. (1998) Abnormalities of nasal potential difference measurement in Liddle's syndrome. J. Clin. Invest., 102, 10-14.
17. Pradervand, S., Barker, P.M., Wang, Q., Ernst, S.A., Beermann, F., Grubb, B.R., Burnier, M., Schmidt, A., Bindels, R.J., Gatzy, J.T. et al. (1999) Salt restriction induces pseudohypoaldosteronism type 1 in mice expressing low levels, of the beta-subunit of the amiloride-sensitive epithelial sodium channel. Proc. Natl Acad. Sci. USA., 96, 1732-1737.
18. + absorption produces cystic fibrosis-like lung disease in mice. Nat. Med., 10, 487-493.
19. Fong, P., Rehfeldt, A. and Jentsch, T.J. (1998) Determinants of slow gating in ClC-0, the voltage-gated chloride channel of Torpedo marmorata. Am. J. Physiol., 274, C966-C973.
20. Knowles, M.R., Paradiso, A.M. and Boucher, R.C. (1995) In vivo nasal potential difference: Techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Hum. Gene Ther., 6, 445-455.
21. Standaert, T.A., Boitano, L., Emerson, J., Milgram, L.J., Konstan, M.W., Hunter, J., Berclaz, P.Y., Brass, L., Zeitlin, P.L., Hammond, K. et al. (2004) Standardized procedure for measurement of nasal potential difference: An outcome measure in multicenter cystic fibrosis clinical trials. Pediatr. Pulmonol., 37, 385-392.